|
| | Cleomiscosin C Basic information |
| Product Name: | Cleomiscosin C | | Synonyms: | Cleomiscosin C;9H-Pyrano[2,3-f]-1,4-benzodioxin-9-one,2,3- dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)- 2-(hydroxymethyl)-5-methoxy-,(2R,3R)-rel- | | CAS: | 84575-10-0 | | MF: | C21H20O9 | | MW: | 416.38 | | EINECS: | | | Product Categories: | | | Mol File: | 84575-10-0.mol |  |
| | Cleomiscosin C Chemical Properties |
| Melting point | 210 °C (decomp) | | Boiling point | 647.8±55.0 °C(Predicted) | | density | 1.391±0.06 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 9.66±0.40(Predicted) |
| | Cleomiscosin C Usage And Synthesis |
| Description | Cleomiscosin C has antioxidant activity, it protects against the oxidative modification of apoB-100 induced by either Cu2+ or HOCl ( IC50s of 23.6 and 3.9 microM, respectively), suggests that it could be beneficial in preventing LDL oxidation in atherosclerotic lesions.
Cleomiscosins A, B and C exhibit liver-protective properties. | | target | SOD | LDL |
| | Cleomiscosin C Preparation Products And Raw materials |
|
